ArticleNature cancer2022

A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.

Laurel B Darragh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.